Which peptides are used for low libido?

PT-141 (bremelanotide) is the primary desire compound, acting on the brain and used on demand. Kisspeptin works upstream on the hormonal axis when low desire is driven by low testosterone. Oxytocin supports connection and the quality of intimacy, and Selank helps when anxiety or stress is the driver. The right compound depends on what's causing the low desire, which is a labs-and-history question.

Is PT-141 taken daily or as needed?

As needed, before intimacy — not as a daily protocol. It's limited to a maximum of once per 24 hours, is always dosed in its own separate syringe, and carries a nausea warning and blood-pressure caution.

When is Kisspeptin used instead of PT-141?

When labs show low testosterone or hormonal decline driving low desire. Kisspeptin works upstream on the reproductive (HPG) axis to restore the body's own hormone signaling — a root-cause approach — whereas PT-141 acts in the moment at the brain level. A clinician uses labs to decide, and they can be complementary.

Are libido peptides FDA-approved?

PT-141 (bremelanotide) is FDA-approved under a brand name for a specific form of low sexual desire in premenopausal women (HSDD). Kisspeptin, Oxytocin research use, and Selank are investigational. All should be used under physician supervision, and low desire warrants evaluation for underlying causes.

Sexual Health & Libido Peptides — Re…

Name: Sexual Health & Libido Peptides — Research Hub
Creator: Dr. Scott DelBoccio, DMD

The Peptide Evidence Index
See how all 34 peptides rank by the strength of real human evidence — one honest scorecard.

View the Index →

Why This Hub Exists

"Libido peptide" isn't one thing

The market treats low desire as a single problem with a single pill. It isn't. Desire can fall short because the brain isn't sending the signal, because hormones have declined, or because stress and anxiety are suppressing it — and those are three different fixes. Reaching for the popular on-demand compound when the real issue is low testosterone treats the moment and ignores the cause. This hub sorts that out.

The core ideaTwo different levels: brain-level, on-demand (PT-141) versus upstream, hormonal (Kisspeptin). Which you need is a labs-and-history question — and Oxytocin or Selank fill in the connection and stress dimensions.

The Landscape

The compounds, by role

Anchor · On-Demand

PT-141

Bremelanotide · melanocortin · brain-level

The primary desire compound — acts on the brain, used as-needed before intimacy. FDA-approved (brand) for HSDD in women. Max once/24h; nausea and blood-pressure cautions; separate syringe always.

Conditional · Hormonal

Kisspeptin

HPG axis · upstream restoration

Added when labs show low testosterone driving low desire — restores the body's own reproductive-hormone signaling. The root-cause route, preferred over direct hormones.

Conditional · Connection

Oxytocin

Bonding · quality of intimacy

Added for the connection and quality dimension of intimacy; pairs with PT-141, and features in the female HSDD combination. Suppressed in pregnancy (uterine contraction).

Conditional · Stress

Selank

Anxiolytic · when stress is the driver

Added when anxiety or stress is suppressing desire — addressing the stress dimension rather than the desire signal directly.

The Differentiator

The cause decides the compound — and the cause needs labs

Sexual Health Selection Logic

Why desire is low routes to what gets used.

If low desire, situational (moderate+)

→

PT-141 anchors — on-demand, brain-level.

If low testosterone on labs (men)

→

Kisspeptin + PT-141 — treat the hormonal cause.

If female HSDD

→

PT-141 + Oxytocin — the desire + connection combination.

If anxiety / stress is the driver

→

Add Selank — address the stress dimension.

As-needed rule: PT-141 and Oxytocin are as-needed, never daily-protocol items · PT-141 always a separate syringe, max once per 24 hours.

Why labs matter hereIf low desire tracks with low testosterone, the upstream Kisspeptin approach targets the cause; if hormones are normal and the gap is situational, PT-141's on-demand action fits. That's not a preference — it's a decision a clinician makes from labs and history. See PT-141 vs Kisspeptin in detail →

Mechanism, Plainly

Three different levels of "desire"

PT-141 works at the brain

It activates melanocortin receptors in the brain to trigger sexual desire directly — a central-nervous-system effect, not a blood-flow one. That's why it's on-demand and why it's the only compound here with an FDA-approved indication.

Kisspeptin works at the hormonal source

It stimulates the reproductive (HPG) axis to restore the body's own hormone signaling — an upstream, root-cause approach when low desire is hormonally driven.

Oxytocin works at connection

The bonding peptide — it supports the connection and quality dimension of intimacy, which is why it pairs with PT-141 rather than replacing it.

Selank removes a brake

When anxiety is suppressing desire, calming the stress response can restore what was there all along — treating the obstacle rather than forcing the signal.

Evidence Snapshot

What the research shows

Compound	Role	Status & evidence
PT-141 (bremelanotide)	Desire, on-demand	FDA-approved (brand) for HSDD in premenopausal women; other uses off-label. Defined safety profile with nausea/BP cautions.
Kisspeptin	Hormonal restoration	Investigational; active reproductive-endocrinology research on the HPG axis.
Oxytocin	Connection	Established hormone; research use for intimacy/bonding is off-label. Suppressed in pregnancy.
Selank	Stress dimension	Investigational anxiolytic; used clinically in Russia, not FDA-approved.

Safety Screen

What gets checked first

Cardiovascular disease. PT-141 and Oxytocin carry blood-pressure effects — a real caution in CVD.
Pregnancy. Oxytocin suppressed (uterine contraction); PT-141 not for use in pregnancy.
PT-141 limits. Max once per 24 hours, nausea common, always a separate syringe — as-needed, never a daily stack item.
Underlying causes. Low desire can be medical, hormonal, psychological, or relational — a peptide is not a substitute for identifying which.
Source quality. Certificate of analysis essential for research-grade material.

Common Questions

Sexual-health peptide questions answered

What's the main libido peptide?

PT-141 (bremelanotide) — it acts on the brain to trigger desire and is used on demand before intimacy. It's the only one here with an FDA-approved indication (HSDD in women). Kisspeptin, Oxytocin, and Selank address hormonal, connection, and stress dimensions respectively.

I have low testosterone — which one?

That points toward Kisspeptin, which works upstream on the hormonal axis to restore your own signaling — a root-cause approach rather than masking the symptom. It's a lab-guided, physician-supervised decision, and it's sometimes paired with PT-141.

Is PT-141 daily?

No — it's as-needed, before intimacy, limited to once per 24 hours. It's always its own separate injection and carries nausea and blood-pressure cautions, so it's never treated as a daily protocol item.

Can they be combined?

Yes, thoughtfully. PT-141 + Oxytocin is the classic female-HSDD combination; Kisspeptin + PT-141 addresses hormonal-plus-situational cases. These are clinician decisions based on labs and history, not blind stacking.

Not Sure Where You Fit?

Take the 60-second quizAnswer a few questions and get honest, clinician-built education matched to your goal — then a personalized report. No hype, no prescription. Which peptide is right for you? →

About the Author

Dr. Scott DelBoccio, DMD

Founding Author · PeptideReport.ai

Dr. DelBoccio is a clinician with thirty years of practice and a focus on peptide pharmacology. PeptideReport.ai is the clinician-authored, education-only reference the peptide space lacked — every hub reflects an independent synthesis of the primary literature and the same selection logic that drives the platform's personalized reports. No products are sold on this site.

Full Disclaimer

This hub is for educational and scientific purposes only, for adults 21 and older, and does not constitute medical advice, diagnosis, or treatment. PT-141 (bremelanotide) is FDA-approved only for HSDD in premenopausal women under a specific brand name; other compounds discussed are investigational or used off-label. Low sexual desire can have medical, hormonal, psychological, or relational causes that require professional evaluation. PT-141 and Oxytocin carry blood-pressure cautions; Oxytocin is contraindicated in pregnancy. Any use should be under the supervision of a qualified physician. PeptideReport.ai does not manufacture, sell, or endorse any preparation. Evidence and regulatory status continue to evolve.